GRANT PICKERING - 15 Aug 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
15 Aug 2022
Net transactions value
-$281,402
Form type
4
Filing time
17 Aug 2022, 17:19:06 UTC
Previous filing
28 Jul 2022
Next filing
30 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $265,412 -10,392 -1.5% $25.54 673,064 15 Aug 2022 Direct F1, F2
transaction PCVX Common Stock Sale $15,990 -608 -0.09% $26.30 672,456 15 Aug 2022 Direct F1, F3
holding PCVX Common Stock 167,830 15 Aug 2022 By Children's Trust F4
holding PCVX Common Stock 167,830 15 Aug 2022 By Children's Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.21 to $26.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The price reported is a weighted-average price. The shares were sold at prices ranging from $26.22 to $26.33. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F5 Shares are held directly by a trust for the benefit of the Reporting Person's son.